\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ or\\ laboratory\\ test\\ results\\ were\\ not\\ available\\.\\ \\ however\\,\\ these\\ tumors\\ are\\ usually\\ found\\ incidentally\\ on\\ radiographs\\ and\\ usually\\ are\\ asymptomatic\\.\\ \\ typical\\ physical\\ findings\\,\\ when\\ present\\,\\ are\\ a\\ nontender\\ mass\\ that\\ grows\\ slowly\\.\\ \\ when\\ patients\\ develop\\ pain\\,\\ symptoms\\ may\\ result\\ from\\ mass\\ effect\\ of\\ the\\ tumor\\,\\ particularly\\ causing\\ irritation\\ and\\ inflammation\\ of\\ neighboring\\ vessels\\,\\ nerve\\,\\ or\\ bursae\\.\\ pain\\ may\\ also\\ result\\ from\\ malignant\\ transformation\\ to\\ chondrosarcoma\\.\ \(0\)\
\-\ treatment\\ usually\\ involves\\ routine\\ monitoring\\ when\\ tumors\\ do\\ not\\ cause\\ clinical\\ problems\\.\\ \\ if\\ patients\\ develop\\ pain\\,\\ then\\ mr\\ imaging\\ should\\ be\\ done\\ to\\ evaluate\\ for\\ adjacent\\ inflammatory\\ changes\\ such\\ as\\ bursitis\\ and\\ for\\ malignant\\ transformation\\.\\ in\\ adults\\,\\ when\\ the\\ cartilaginous\\ cap\\ measures\\ greater\\ than\\ 1\\ cm\\,\\ the\\ possibility\\ of\\ chondrosarcomatous\\ transformation\\ should\\ be\\ considered\\.\\ in\\ addition\\,\\ \\ contrast\\-enhanced\\ mr\\ imaging\\ may\\ help\\ differentiate\\ \\ the\\ benign\\ osteochondroma\\ \\ \\(enhancement\\ usually\\ only\\ of\\ the\\ fibrovasular\\ tissue\\ around\\ the\\ cartilaginous\\ cap\\)\\ from\\ chondrosarcoma\\.\\ typically\\ with\\ low\\ grade\\ chondrosarcoma\\,\\ fibrovascular\\ tissue\\ between\\ lobules\\ enhances\\ whereas\\ in\\ high\\ grade\\ chondrosarcoma\\ may\\ be\\ more\\ extensive\\.\\ \\ when\\ patients\\ have\\ positive\\ mr\\ imaging\\ findings\\ and\\ \\ clinical\\ symptomatology\\ and\\/or\\ when\\ osteochondromas\\ cause\\ pathologic\\ fractures\\,\\ surgical\\ resection\\ is\\ indicated\\.\ \(0\)\
\-\ radiographs\\ showed\\ an\\ osseous\\ pedunculated\\ mass\\ continuous\\ with\\ and\\ extending\\ from\\ the\\ medullary\\ \\ and\\ cortical\\ bone\\ of\\ the\\ medial\\ tibial\\ metaphysis\\ and\\ pointing\\ away\\ from\\ the\\ joint\\.\\ the\\ mass\\ \\ measures\\ 1\\.1x1\\.16cm\\ \\.\\ \\ stippled\\ calcifications\\ are\\ consistent\\ with\\ the\\ cartilaginous\\ component\\ of\\ the\\ lesion\\.\ \(0\)\
\-\ osteochondroma\ \(97\)\
\-\ 1\\.\\ peripheral\\ osteochondroma\ \(0\)\
\-\ 2\\.\\ peripheral\\ chondrosarcoma\ \(0\)\
\-\ the\\ patient\\ complained\\ of\\ right\\ knee\\ pain\\,\\ was\\ evaluated\\ at\\ the\\ pain\\ clinic\\,\\ and\\ received\\ celecoxib\\ qd\\ for\\ pain\\ with\\ variable\\ results\\.\\ the\\ patient\\ walked\\ into\\ orthopaedics\\ clinic\\ seeking\\ further\\ evaluation\\ and\\ treatment\\ because\\ of\\ continuing\\ pain\\ in\\ the\\ right\\ knee\\ that\\ had\\ not\\ resolved\\ completely\\ with\\ medical\\ management\\.\ \(0\)\
\-\ the\\ characteristic\\ radiographic\\ findings\\ of\\ these\\ tumors\\ \\ are\\ a\\ \\ pedunculated\\ or\\ sessile\\ mass\\ projecting\\ from\\ and\\ continuous\\ with\\ the\\ metaphysis\\ of\\ \\ long\\ bones\\,\\ most\\ frequently\\ the\\ tibia\\,\\ femur\\,\\ or\\ humerus\\.\\ \\ typically\\,\\ these\\ masses\\ point\\ toward\\ the\\ diaphysis\\ and\\ away\\ from\\ the\\ joint\\.\\ axial\\ involvement\\ is\\ less\\ common\\ with\\ single\\ osteochondromas\\ than\\ multiple\\ osteochondromas\\.\\ on\\ the\\ radiographs\\,\\ the\\ cartilaginous\\ cap\\ appears\\ as\\ stippled\\ calcifications\\.\\ mr\\ imaging\\ confirms\\ the\\ \\ tumor\\â\\€\\™s\\ continuity\\ with\\ medullary\\ and\\ cortical\\ bone\\ and\\ shows\\ the\\ high\\-signal\\-intensity\\ cartilaginous\\ cap\\ surrounded\\ by\\ low\\-signal\\-intensity\\ perichondrium\\.\\ \\ osteochondromas\\ are\\ found\\ among\\ all\\ ages\\,\\ although\\ most\\ commonly\\ found\\ in\\ males\\ less\\ than\\ 20\\ years\\ of\\ age\\.\\ \\ most\\ are\\ asymptomatic\\ and\\ found\\ as\\ an\\ incidental\\ finding\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cartilaginous\\:\\ 0\\.2681651382699603\ \(0\)\
\-\ the\\:\\ 0\\.2366744076442701\ \(0\)\
\-\ osteochondromas\\:\\ 0\\.23646468184821254\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.2175264442041236\ \(0\)\
\-\ cap\\:\\ 0\\.2134042332900785\ \(0\)\
\-\ when\\:\\ 0\\.17195678242825654\ \(0\)\
\-\ osteochondroma\\:\\ 0\\.15049679208919844\ \(0\)\
\-\ and\\:\\ 0\\.14705860966032808\ \(0\)\
\-\ transformation\\:\\ 0\\.14538678318675846\ \(0\)\
\-\ stippled\\:\\ 0\\.13347446833895735\ \(0\)\
\-\ from\\:\\ 0\\.13190171427983216\ \(0\)\
\-\ are\\:\\ 0\\.1260222671300734\ \(0\)\
\-\ found\\:\\ 0\\.12279604678060184\ \(0\)\
\-\ mr\\:\\ 0\\.12279604678060184\ \(0\)\
\-\ usually\\:\\ 0\\.11947328467548915\ \(0\)\
\-\ pain\\:\\ 0\\.11884271383023609\ \(0\)\
\-\ pedunculated\\:\\ 0\\.10615667114396322\ \(0\)\
\-\ tumors\\:\\ 0\\.1046798402494468\ \(0\)\
\-\ of\\:\\ 0\\.10213232196178958\ \(0\)\
\-\ imaging\\:\\ 0\\.09973559822246782\ \(0\)\
\-\ continuous\\:\\ 0\\.09959175755259074\ \(0\)\
\-\ away\\:\\ 0\\.09854080196071645\ \(0\)\
\-\ may\\:\\ 0\\.09550307488564681\ \(0\)\
\-\ radiographs\\:\\ 0\\.09231639382641686\ \(0\)\
\-\ mass\\:\\ 0\\.09061342246212681\ \(0\)\
\-\ develop\\:\\ 0\\.08735357122268929\ \(0\)\
\-\ metaphysis\\:\\ 0\\.087181190432538\ \(0\)\
\-\ medullary\\:\\ 0\\.08392124773334646\ \(0\)\
\-\ or\\:\\ 0\\.08252617600129541\ \(0\)\
\-\ than\\:\\ 0\\.08068549131560278\ \(0\)\
\-\ these\\:\\ 0\\.0803763792209543\ \(0\)\
\-\ patients\\:\\ 0\\.08007104969423369\ \(0\)\
\-\ clinic\\:\\ 0\\.07992976495112115\ \(0\)\
\-\ measures\\:\\ 0\\.07736553045514716\ \(0\)\
\-\ chondrosarcomatous\\:\\ 0\\.0758747207230916\ \(0\)\
\-\ fibrovasular\\:\\ 0\\.0758747207230916\ \(0\)\
\-\ celecoxib\\:\\ 0\\.0758747207230916\ \(0\)\
\-\ with\\:\\ 0\\.07432243345441815\ \(0\)\
\-\ most\\:\\ 0\\.0740752848921713\ \(0\)\
\-\ results\\:\\ 0\\.07394126441202035\ \(0\)\
\-\ perichondrium\\:\\ 0\\.07250234630901217\ \(0\)\
\-\ result\\:\\ 0\\.07103787149271408\ \(0\)\
\-\ findings\\:\\ 0\\.07024788059849552\ \(0\)\
\-\ calcifications\\:\\ 0\\.06925278397288226\ \(0\)\
\-\ grade\\:\\ 0\\.06823402092443681\ \(0\)\
\-\ cortical\\:\\ 0\\.06812458238899526\ \(0\)\
\-\ knee\\:\\ 0\\.06801585914320851\ \(0\)\
\-\ peripheral\\:\\ 0\\.06785409517097812\ \(0\)\
\-\ malignant\\:\\ 0\\.06764082818072693\ \(0\)\
\-\ neighboring\\:\\ 0\\.06673723416947867\ \(0\)\
\-\ bursae\\:\\ 0\\.06673723416947867\ \(0\)\
\-\ fibrovascular\\:\\ 0\\.06673723416947867\ \(0\)\
\-\ typically\\:\\ 0\\.06661367494364753\ \(0\)\
\-\ cause\\:\\ 0\\.06464333765020068\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.0645991554266498\ \(0\)\
\-\ less\\:\\ 0\\.06455509024223877\ \(0\)\
\-\ lobules\\:\\ 0\\.06434449644402458\ \(0\)\
\-\ walked\\:\\ 0\\.06434449644402458\ \(0\)\
\-\ seeking\\:\\ 0\\.06434449644402458\ \(0\)\
\-\ joint\\:\\ 0\\.06252750220064647\ \(0\)\
\-\ orthopaedics\\:\\ 0\\.06248854487613255\ \(0\)\
\-\ should\\:\\ 0\\.06191558594640021\ \(0\)\
\-\ grows\\:\\ 0\\.06030638292195794\ \(0\)\
\-\ clinical\\:\\ 0\\.06013669201601522\ \(0\)\
\-\ pointing\\:\\ 0\\.059116170462053134\ \(0\)\
\-\ in\\:\\ 0\\.05901375422977998\ \(0\)\
\-\ sessile\\:\\ 0\\.05807515121664065\ \(0\)\
\-\ be\\:\\ 0\\.05773949515245913\ \(0\)\
\-\ as\\:\\ 0\\.057180898119759155\ \(0\)\
\-\ bursitis\\:\\ 0\\.057150054387013094\ \(0\)\
\-\ not\\:\\ 0\\.05619035143108523\ \(0\)\
\-\ irritation\\:\\ 0\\.05593070950259966\ \(0\)\
\-\ continuing\\:\\ 0\\.055560990915828876\ \(0\)\
\-\ qd\\:\\ 0\\.054867481168707016\ \(0\)\
\-\ low\\:\\ 0\\.05444827874159241\ \(0\)\
\-\ high\\:\\ 0\\.05392914279203905\ \(0\)\
\-\ symptomatology\\:\\ 0\\.05392489264242465\ \(0\)\
\-\ bone\\:\\ 0\\.05177483024715361\ \(0\)\
\-\ physical\\:\\ 0\\.051451425700954206\ \(0\)\
\-\ continuity\\:\\ 0\\.05138494224747959\ \(0\)\
\-\ projecting\\:\\ 0\\.05075294476261931\ \(0\)\
\-\ whereas\\:\\ 0\\.05035680805296922\ \(0\)\
\-\ among\\:\\ 0\\.05016559736306615\ \(0\)\
\-\ differentiate\\:\\ 0\\.04997868390844021\ \(0\)\
\-\ tissue\\:\\ 0\\.04977704821845848\ \(0\)\
\-\ tumor\\:\\ 0\\.04963286879027617\ \(0\)\
\-\ males\\:\\ 0\\.04893766466302772\ \(0\)\
\-\ surrounded\\:\\ 0\\.04877615864289092\ \(0\)\
\-\ toward\\:\\ 0\\.04861772911574051\ \(0\)\
\-\ ages\\:\\ 0\\.04846226106225282\ \(0\)\
\-\ monitoring\\:\\ 0\\.04731322343244811\ \(0\)\
\-\ slowly\\:\\ 0\\.04679322294898673\ \(0\)\
\-\ diaphysis\\:\\ 0\\.04618585108890744\ \(0\)\
\-\ variable\\:\\ 0\\.046069523336798736\ \(0\)\
\-\ confirms\\:\\ 0\\.04584163788457044\ \(0\)\
\-\ complained\\:\\ 0\\.04572999461509409\ \(0\)\
\-\ treatment\\:\\ 0\\.04520104487029736\ \(0\)\
\-\ particularly\\:\\ 0\\.044787406088811724\ \(0\)\
\-\ humerus\\:\\ 0\\.044787406088811724\ \(0\)\
\-\ nontender\\:\\ 0\\.044688975369681604\ \(0\)\
\-\ adults\\:\\ 0\\.04430650344737774\ \(0\)\
\-\ possibility\\:\\ 0\\.044121666980824495\ \(0\)\
\-\ help\\:\\ 0\\.043590595216269\ \(0\)\
\-\ for\\:\\ 0\\.04314055339906786\ \(0\)\
\-\ resolved\\:\\ 0\\.04262049124925324\ \(0\)\
\-\ completely\\:\\ 0\\.04239466836335763\ \(0\)\
\-\ enhances\\:\\ 0\\.04182083404345261\ \(0\)\
\-\ involves\\:\\ 0\\.04128404788589055\ \(0\)\
\-\ received\\:\\ 0\\.04128404788589055\ \(0\)\
\-\ that\\:\\ 0\\.04117861296885556\ \(0\)\
\-\ problems\\:\\ 0\\.04115509493546539\ \(0\)\
\-\ tibial\\:\\ 0\\.04096533844587966\ \(0\)\
\-\ component\\:\\ 0\\.04065839222268244\ \(0\)\
\-\ evaluated\\:\\ 0\\.040538716795465606\ \(0\)\
\-\ tibia\\:\\ 0\\.040538716795465606\ \(0\)\
\-\ incidentally\\:\\ 0\\.04042073894937393\ \(0\)\
\-\ do\\:\\ 0\\.0393247745086399\ \(0\)\
\-\ point\\:\\ 0\\.03922272048355229\ \(0\)\
\-\ frequently\\:\\ 0\\.03907194961135727\ \(0\)\
\-\ indicated\\:\\ 0\\.03902229394927821\ \(0\)\
\-\ causing\\:\\ 0\\.03897293298129078\ \(0\)\
\-\ femur\\:\\ 0\\.0389238632301481\ \(0\)\
\-\ pathologic\\:\\ 0\\.03887508127978725\ \(0\)\
\-\ test\\:\\ 0\\.038588249452593815\ \(0\)\
\-\ addition\\:\\ 0\\.03840238029437126\ \(0\)\
\-\ characteristic\\:\\ 0\\.03835655484129099\ \(0\)\
\-\ bones\\:\\ 0\\.03817573687883518\ \(0\)\
\-\ inflammation\\:\\ 0\\.038131139996148714\ \(0\)\
\-\ around\\:\\ 0\\.03786846662818427\ \(0\)\
\-\ osseous\\:\\ 0\\.03786846662818427\ \(0\)\
\-\ done\\:\\ 0\\.037740176701291206\ \(0\)\
\-\ considered\\:\\ 0\\.03697063220601018\ \(0\)\
\-\ evaluate\\:\\ 0\\.036893619630848175\ \(0\)\
\-\ vessels\\:\\ 0\\.03681731360303035\ \(0\)\
\-\ routine\\:\\ 0\\.03674170127597348\ \(0\)\
\-\ typical\\:\\ 0\\.03666677015030882\ \(0\)\
\-\ extensive\\:\\ 0\\.03655562419308075\ \(0\)\
\-\ single\\:\\ 0\\.036482343554333156\ \(0\)\
\-\ an\\:\\ 0\\.036285539488283836\ \(0\)\
\-\ radiographic\\:\\ 0\\.035200226306346144\ \(0\)\
\-\ incidental\\:\\ 0\\.03516901689376482\ \(0\)\
\-\ commonly\\:\\ 0\\.0351069472124621\ \(0\)\
\-\ fractures\\:\\ 0\\.03507608521529378\ \(0\)\
\-\ management\\:\\ 0\\.03504533731079679\ \(0\)\
\-\ greater\\:\\ 0\\.03495376979481755\ \(0\)\
\-\ appears\\:\\ 0\\.03474395293577856\ \(0\)\
\-\ laboratory\\:\\ 0\\.03445310866265607\ \(0\)\
\-\ involvement\\:\\ 0\\.034339560159247697\ \(0\)\
\-\ nerve\\:\\ 0\\.03384694457121229\ \(0\)\
\-\ then\\:\\ 0\\.03358537274102865\ \(0\)\
\-\ effect\\:\\ 0\\.03328197258426496\ \(0\)\
\-\ because\\:\\ 0\\.033158751090614585\ \(0\)\
\-\ benign\\:\\ 0\\.032591442701757484\ \(0\)\
\-\ masses\\:\\ 0\\.0322995777133249\ \(0\)\
\-\ although\\:\\ 0\\.0322995777133249\ \(0\)\
\-\ available\\:\\ 0\\.03218999380013154\ \(0\)\
\-\ extending\\:\\ 0\\.03216824921599753\ \(0\)\
\-\ inflammatory\\:\\ 0\\.032081834945743376\ \(0\)\
\-\ showed\\:\\ 0\\.03160165677612676\ \(0\)\
\-\ long\\:\\ 0\\.03146085271003019\ \(0\)\
\-\ right\\:\\ 0\\.031459893533942546\ \(0\)\
\-\ positive\\:\\ 0\\.031263751100323235\ \(0\)\
\-\ finding\\:\\ 0\\.03118619996790819\ \(0\)\
\-\ further\\:\\ 0\\.03090165801077532\ \(0\)\
\-\ medial\\:\\ 0\\.030883030234357615\ \(0\)\
\-\ patient\\:\\ 0\\.030862887078186158\ \(0\)\
\-\ between\\:\\ 0\\.030827395921947658\ \(0\)\
\-\ adjacent\\:\\ 0\\.030753791028363127\ \(0\)\
\-\ 20\\:\\ 0\\.030608507007853298\ \(0\)\
\-\ such\\:\\ 0\\.030518976555697547\ \(0\)\
\-\ resection\\:\\ 0\\.030412796832477287\ \(0\)\
\-\ medical\\:\\ 0\\.030153130622856145\ \(0\)\
\-\ age\\:\\ 0\\.029786376676535168\ \(0\)\
\-\ only\\:\\ 0\\.02964088086094521\ \(0\)\
\-\ years\\:\\ 0\\.029083087623531987\ \(0\)\
\-\ evaluation\\:\\ 0\\.028934560485655215\ \(0\)\
\-\ changes\\:\\ 0\\.028673717895248578\ \(0\)\
\-\ on\\:\\ 0\\.02865834716313048\ \(0\)\
\-\ all\\:\\ 0\\.028242817432070754\ \(0\)\
\-\ however\\:\\ 0\\.028081832431678784\ \(0\)\
\-\ shows\\:\\ 0\\.027846050695628424\ \(0\)\
\-\ if\\:\\ 0\\.0275666647773446\ \(0\)\
\-\ axial\\:\\ 0\\.027405879275135558\ \(0\)\
\-\ enhancement\\:\\ 0\\.02730845738597743\ \(0\)\
\-\ cm\\:\\ 0\\.027248143135491114\ \(0\)\
\-\ common\\:\\ 0\\.026906691561230493\ \(0\)\
\-\ more\\:\\ 0\\.026052323597716413\ \(0\)\
\-\ is\\:\\ 0\\.025986215329122098\ \(0\)\
\-\ symptoms\\:\\ 0\\.02595916059723081\ \(0\)\
\-\ consistent\\:\\ 0\\.025725712850477103\ \(0\)\
\-\ into\\:\\ 0\\.02522089103152087\ \(0\)\
\-\ were\\:\\ 0\\.024456474003040705\ \(0\)\
\-\ present\\:\\ 0\\.024345518142027397\ \(0\)\
\-\ exam\\:\\ 0\\.023883785395472215\ \(0\)\
\-\ to\\:\\ 0\\.02372226261939416\ \(0\)\
\-\ have\\:\\ 0\\.023701328989714453\ \(0\)\
\-\ had\\:\\ 0\\.02363879261469781\ \(0\)\
\-\ multiple\\:\\ 0\\.023206332214522125\ \(0\)\
\-\ surgical\\:\\ 0\\.023059768092631307\ \(0\)\
\-\ lesion\\:\\ 0\\.022746139553986272\ \(0\)\
\-\ also\\:\\ 0\\.022316720292145275\ \(0\)\
\-\ by\\:\\ 0\\.02014785538108081\ \(0\)\
\-\ at\\:\\ 0\\.017920538619913877\ \(0\)\
\-\ was\\:\\ 0\\.016535016687517116\ \(0\)\
